Several groups have developed molecules, such as aptamers (AS1411), pseudopeptides (HB-19 and N6L) or antibodies (4LB5) that bind to membrane NCL in cancer cells 4,24,40,48. This evidence concerns the gene NUCLEOLIN and cancer.